UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 39

Sortiert nach

Testing the H56 Vaccine Delivered in 4 Different Adjuvants as a BCG-Booster in a Non-Human Primate Model of Tuberculosis

PloS one, 2016-08, Vol.11 (8), p.e0161217-e0161217

2016

Volltextzugriff (PDF)

The multistage vaccine H56 boosts the effects of BCG to protect cynomolgus macaques against active tuberculosis and reactivation of latent Mycobacterium tuberculosis infection

The Journal of clinical investigation, 2012-01, Vol.122 (1), p.303-314

2012

Volltextzugriff (PDF)

Defined tuberculosis vaccine, Mtb72F/AS02A, evidence of protection in cynomolgus monkeys

Proceedings of the National Academy of Sciences - PNAS, 2009-02, Vol.106 (7), p.2301-2306

2009

Volltextzugriff (PDF)

Powerful Bactericidal Activity of Moxifloxacin in Human Leprosy

Antimicrobial Agents and Chemotherapy, 2008-09, Vol.52 (9), p.3113-3117

2008

Volltextzugriff (PDF)

Limited Susceptibility of Cynomolgus Monkeys (Macaca fascicularis) to Leprosy after Experimental Administration of Mycobacterium leprae

The American journal of tropical medicine and hygiene, 2012-08, Vol.87 (2), p.327-336

2012

Volltextzugriff (PDF)

Methods for the Classification of Leprosy for Treatment Purposes

Clinical infectious diseases, 2007-04, Vol.44 (8), p.1096-1099

2007

Volltextzugriff (PDF)

Reactions Following Completion of 1 and 2 Year Multidrug Therapy (MDT)

The American journal of tropical medicine and hygiene, 2010-09, Vol.83 (3), p.637-644

2010

Volltextzugriff (PDF)

Psoriasis is characterized by altered epidermal expression of caspase 14, a novel regulator of keratinocyte terminal differentiation and barrier formation

Journal of dermatological science, 2005, Vol.37 (1), p.61-63

2005

Volltextzugriff (PDF)

Rapid killing of M. leprae by moxifloxacin in two patients with lepromatous leprosy

Leprosy review, 2009-06, Vol.80 (2), p.205-209

2009

Volltextzugriff (PDF)

Long-term relapse risk of multibacillary leprosy after completion of 2 years of multiple drug therapy (WHO-MDT) in Cebu, Philippines

The American journal of tropical medicine and hygiene, 2009-11, Vol.81 (5), p.895

2009

Volltextzugriff (PDF)

A comparative clinical trial in multibacillary leprosy with long-term relapse rates of four different multidrug regimens

The American journal of tropical medicine and hygiene, 2009-08, Vol.81 (2), p.330

2009

Volltextzugriff (PDF)

The Philippine cynomolgus monkey ( Macaca fasicularis ) provides a new nonhuman primate model of tuberculosis that resembles human disease

Nature medicine, 1996-04, Vol.2 (4), p.430-436

1996

Volltextzugriff (PDF)

A clinical trial of ethionamide and prothionamide for treatment of lepromatous leprosy

The American journal of tropical medicine and hygiene, 2006-03, Vol.74 (3), p.457

2006

Volltextzugriff (PDF)

The efficacy of a four-week, ofloxacin-containing regimen compared with standard WHO-MDT in PB leprosy

Leprosy review, 2010-03, Vol.81 (1), p.27-33

2010

Volltextzugriff (PDF)

Clinical and histological features of inoculation site skin lesions in cynomolgus monkeys experimentally infected with Orientia tsutsugamushi

Vector borne and zoonotic diseases (Larchmont, N.Y.), 2007-12, Vol.7 (4), p.547

2007

Volltextzugriff (PDF)

LONGITUDINAL OCULAR SURVEY OF 202 FILIPINO PATIENTS WITH MULTI-BACILLARY (MB) LEPROSY TREATED WITH 2 YEAR WHO-MULTIPLE DRUG THERAPY

Southeast Asian journal of tropical medicine and public health, 2011-03, Vol.42 (2), p.323-330

2011

Volltextzugriff (PDF)

Parallel assessment of 24 monthly doses of rifampin, ofloxacin, and minocycline versus two years of World Health Organization multi-drug therapy for multi-bacillary leprosy

The American journal of tropical medicine and hygiene, 2004-02, Vol.70 (2), p.197

2004

Volltextzugriff (PDF)

Clinical and histologic features of skin lesions in a cynomolgus monkey experimentally infected with mycobacterium ulcerans (Buruli ulcer) by intradermal inoculation

The American journal of tropical medicine and hygiene, 2007-01, Vol.76 (1), p.132

2007

Volltextzugriff (PDF)

GM-CSF Activates Regenerative Epidermal Growth and Stimulates Keratinocyte Proliferation in Human Skin In Vivo

Journal of investigative dermatology, 1994-10, Vol.103 (4), p.601-604

1994

Volltextzugriff (PDF)

Long-term efficacy of 2 year WHO multiple drug therapy (MDT) in multibacillary (MB) leprosy patients

International journal of leprosy and other mycobacterial diseases, 2003-12, Vol.71 (4), p.308-319

2003

Volltextzugriff (PDF)

TUNEL and limited immunophenotypic analyses of apoptosis in paucibacillary and multibacillary leprosy lesions

FEMS immunology and medical microbiology, 2004-07, Vol.41 (3), p.265-269

2004

Volltextzugriff (PDF)

A clinical trial of pefloxacin and ofloxacin in lepromatous leprosy

Leprosy review, 2004-12, Vol.75 (4), p.389-397

2004

Volltextzugriff (PDF)

Clofazimine therapy for lepromatous leprosy:a historical perspective

International journal of dermatology, 1999-01, Vol.38 (1), p.70-74

1999

Volltextzugriff (PDF)

A randomized, double-blind, double-dummy, controlled dose comparison of thalidomide for treatment of erythema nodosum leprosum

The American journal of tropical medicine and hygiene, 2005-05, Vol.72 (5), p.518

2005

Volltextzugriff (PDF)

The efficacy of a four-week, ofloxacin-containing regimen compared with standard WHO-MDT in PB leprosy

Leprosy review, 2010-03, Vol.80 (1), p.27

2010

Volltextzugriff (PDF)

1 – 25 von 39

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(36)
Mit Volltextzugriff
(30)

Publikationsform

Artikel
(39)

Sprache

Englisch
(39)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

Science & Technology
(31)
Humans
(28)
Life Sciences & Biomedicine
(28)
Infectious Diseases
(21)
Male
(21)
Biological And Medical Sciences
(20)
Adult
(19)
Medical Sciences
(19)
Leprosy
(18)
Tropical Medicine
(16)
Bacterial Diseases
(15)
Human Bacterial Diseases
(15)
Middle Aged
(15)
Tropical Bacterial Diseases
(15)
Female
(14)
Adolescent
(13)
Animals
(13)
Leprostatic Agents - Therapeutic Use
(12)
Dermatology
(10)
Leprosy - Drug Therapy
(10)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Testing the H56 Vaccine Delivered in 4 Different Adjuvants as a BCG-Booster in a Non-Human Primate Model of Tuberculosis

The multistage vaccine H56 boosts the effects of BCG to protect cynomolgus macaques against active tuberculosis and reactivation of latent Mycobacterium tuberculosis infection

Defined tuberculosis vaccine, Mtb72F/AS02A, evidence of protection in cynomolgus monkeys

Powerful Bactericidal Activity of Moxifloxacin in Human Leprosy

Limited Susceptibility of Cynomolgus Monkeys (Macaca fascicularis) to Leprosy after Experimental Administration of Mycobacterium leprae

Methods for the Classification of Leprosy for Treatment Purposes

Reactions Following Completion of 1 and 2 Year Multidrug Therapy (MDT)

Psoriasis is characterized by altered epidermal expression of caspase 14, a novel regulator of keratinocyte terminal differentiation and barrier formation

Rapid killing of M. leprae by moxifloxacin in two patients with lepromatous leprosy

Long-term relapse risk of multibacillary leprosy after completion of 2 years of multiple drug therapy (WHO-MDT) in Cebu, Philippines

A comparative clinical trial in multibacillary leprosy with long-term relapse rates of four different multidrug regimens

The Philippine cynomolgus monkey ( Macaca fasicularis ) provides a new nonhuman primate model of tuberculosis that resembles human disease

A clinical trial of ethionamide and prothionamide for treatment of lepromatous leprosy

The efficacy of a four-week, ofloxacin-containing regimen compared with standard WHO-MDT in PB leprosy

Clinical and histological features of inoculation site skin lesions in cynomolgus monkeys experimentally infected with Orientia tsutsugamushi

LONGITUDINAL OCULAR SURVEY OF 202 FILIPINO PATIENTS WITH MULTI-BACILLARY (MB) LEPROSY TREATED WITH 2 YEAR WHO-MULTIPLE DRUG THERAPY

Parallel assessment of 24 monthly doses of rifampin, ofloxacin, and minocycline versus two years of World Health Organization multi-drug therapy for multi-bacillary leprosy

Clinical and histologic features of skin lesions in a cynomolgus monkey experimentally infected with mycobacterium ulcerans (Buruli ulcer) by intradermal inoculation

GM-CSF Activates Regenerative Epidermal Growth and Stimulates Keratinocyte Proliferation in Human Skin In Vivo

Long-term efficacy of 2 year WHO multiple drug therapy (MDT) in multibacillary (MB) leprosy patients

TUNEL and limited immunophenotypic analyses of apoptosis in paucibacillary and multibacillary leprosy lesions

A clinical trial of pefloxacin and ofloxacin in lepromatous leprosy

Clofazimine therapy for lepromatous leprosy:a historical perspective

A randomized, double-blind, double-dummy, controlled dose comparison of thalidomide for treatment of erythema nodosum leprosum

The efficacy of a four-week, ofloxacin-containing regimen compared with standard WHO-MDT in PB leprosy

Suchergebnisse filtern